Cargando…

Dose-response assessment of tariquidar for inhibition of P-glycoprotein at the human blood-brain barrier using (R)-[(11)C]verapamil PET

Detalles Bibliográficos
Autores principales:	Bauer, Martin, Zeitlinger, Markus, Matzneller, Peter, Stanek, Johann, Lackner, Edith, Wadsak, Wolfgang, Müller, Markus, Langer, Oliver
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016559/ http://dx.doi.org/10.1186/1471-2210-10-S1-A47

Ejemplares similares

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[(11)C]verapamil PET study
por: Bauer, Martin, et al.
Publicado: (2015)

Inhibition of breast cancer resistance protein at the murine blood-brain barrier by Ko143 studied with [(11)C]tariquidar and PET
por: Wanek, Thomas, et al.
Publicado: (2011)

Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration
por: Matzneller, Peter, et al.
Publicado: (2018)

[(11)C]Elacridar as a novel P-glycoprotein PET tracer, assessment of whole-body distribution and radiation dosimetry in humans
por: Bauer, Martin, et al.
Publicado: (2011)

Small-animal PET evaluation of [(11)C]MC113 as a PET tracer for P-glycoprotein
por: Mairinger, Severin, et al.
Publicado: (2010)

A combined accelerator mass spectrometry/positron emission tomography microdose study to assess the plasma and brain tissue pharmacokinetics of (11)C- and (14)C-labelled verapamil in healthy volunteers
por: Wagner, Claudia C, et al.
Publicado: (2008)

(R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood–brain barrier, and not by MRP1 and BCRP
por: Römermann, Kerstin, et al.
Publicado: (2013)

Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood–brain barriers studied with (R)-[(11)C]verapamil positron emission tomography
por: Müllauer, Julia, et al.
Publicado: (2012)

Characterization of colistin tissue pharmacokinetics by microdialysis
por: Matzneller, Peter, et al.
Publicado: (2012)

Decreased blood-brain barrier P-glycoprotein function with aging
por: Bauer, Martin, et al.
Publicado: (2008)

Tissue pharmacokinetics of individual macrolides support observed differences in development of bacterial resistance
por: Krasniqi, Shaip, et al.
Publicado: (2010)

In vivo P-glycoprotein function before and after epilepsy surgery
por: Bauer, Martin, et al.
Publicado: (2014)

Mapping the Binding Site of the Inhibitor Tariquidar That Stabilizes the First Transmembrane Domain of P-glycoprotein
por: Loo, Tip W., et al.
Publicado: (2015)

P-Glycoprotein Inhibitor Tariquidar Plays an Important Regulatory Role in Pigmentation in Larval Zebrafish
por: Kasica, Natalia, et al.
Publicado: (2021)

P-glycoprotein Inhibitor Tariquidar Potentiates Efficacy of Astragaloside IV in Experimental Autoimmune Encephalomyelitis Mice
por: Zhang, Wei, et al.
Publicado: (2019)

EHMTI-0021. The possible effect of telmisartan on the blood-brain barrier transport of verapamil
por: Saaby, PL, et al.
Publicado: (2014)

Comparison of fully-automated radiosyntheses of [(11)C]erlotinib for preclinical and clinical use starting from in target produced [(11)C]CO(2) or [(11)C]CH(4)
por: Philippe, Cécile, et al.
Publicado: (2018)

Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [(11)C]Metoclopramide
por: Bauer, Martin, et al.
Publicado: (2021)

Pilot PET Study to Assess the Functional Interplay Between ABCB1 and ABCG2 at the Human Blood–Brain Barrier
por: Bauer, M, et al.
Publicado: (2016)

Factors Governing P-Glycoprotein-Mediated Drug–Drug Interactions at the Blood–Brain Barrier Measured with Positron Emission Tomography
por: Wanek, Thomas, et al.
Publicado: (2015)

(R)-[(11)C]Verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus
por: Syvänen, Stina, et al.
Publicado: (2011)

Effect of the human endotoxin challenge on tedizolid tissue penetration
por: Jorda, Anselm, et al.
Publicado: (2022)

Reversal of MRP7 (ABCC10)-Mediated Multidrug Resistance by Tariquidar
por: Sun, Yue-Li, et al.
Publicado: (2013)

Pharmacokinetic Modeling of (R)-[(11)C]verapamil to Measure the P-Glycoprotein Function in Nonhuman Primates
por: García-Varela, Lara, et al.
Publicado: (2020)

Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis
por: Bauer, Martin, et al.
Publicado: (2021)

Functionalized Lipid Nanocarriers for Simultaneous Delivery of Docetaxel and Tariquidar to Chemoresistant Cancer Cells
por: Kim, Chang Hyun, et al.
Publicado: (2023)

Combined verapamil and atenolol poisoning: resolution of cardiogenic shock with enoximone
por: Gallizzi, F, et al.
Publicado: (2001)

Prospective evaluation of the performance of [(68)Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy
por: Abufaraj, Mohammad, et al.
Publicado: (2019)

Verapamil and Rifampin Effect on P-Glycoprotein Expression in Hepatocellular Carcinoma
por: Jalali, Amir, et al.
Publicado: (2014)

[(11)C]acetate PET as a tool for diagnosis of liver steatosis
por: Nejabat, Marzieh, et al.
Publicado: (2018)

Synthesis and Evaluation of New Fluorine-18 Labeled Verapamil Analogs To Investigate the Function of P-Glycoprotein in the Blood–Brain Barrier
por: Raaphorst, Renske M., et al.
Publicado: (2017)

Impact of Cytochrome Induction or Inhibition on the Plasma and Brain Kinetics of [(11)C]metoclopramide, a PET Probe for P-Glycoprotein Function at the Blood-Brain Barrier
por: Breuil, Louise, et al.
Publicado: (2022)

Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer Drugs
por: Bauer, Martin, et al.
Publicado: (2020)

The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab
por: Li, Shuren, et al.
Publicado: (2017)

Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice
por: Gardner, Erin R, et al.
Publicado: (2009)

Reproducibility of quantitative (R)-[(11)C]verapamil studies
por: van Assema, Daniëlle ME, et al.
Publicado: (2012)

Antimicrobial activity of antibiotics in urine under different physiological conditions
por: Burian, Angela, et al.
Publicado: (2010)

Does pulmonary surfactant generally affect antimicrobial activity?
por: Schwameis, Richard, et al.
Publicado: (2012)

Influence of OATPs on Hepatic Disposition of Erlotinib Measured With Positron Emission Tomography
por: Bauer, Martin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9vs2822kqjjs6pch7vimcuv81u